Real-World Evidence Will Take Center Stage At US FDA Advisory Committee On COVID Boosters

 
• By Sue Sutter
  
How will the advisory committee discussion run for the RWE on boosters for Pfizer’s COVID vaccine Comirnaty? • Source: Nielsen Hobbs

More from US FDA Performance Tracker

More from Regulatory Trackers